India Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
India Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the India Cell and Gene Therapy Manufacturing QC Market was valued at USD 116.84 Million in 2024 and is projected to reach USD 305.8 Million by 2028, expanding at a CAGR of 27.3% during the forecast period. The primary applications driving this demand are in the medicinal and pharmaceutical industries, where cell and gene therapies are increasingly being utilized for treating a broad spectrum of diseases. Key market drivers include the technological advancements in gene editing tools and the growing demand in the sectors of agriculture and chemicals for efficient and sustainable treatments. The market presents potential opportunities in the adoption of green, low-carbon production methods, and harnessing the benefits of transgenic products. As India continues to invest in research and development in this field, the country is prominently positioning itself for robust growth in the Cell and Gene Therapy Manufacturing QC Market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market Highlights
- Cell Therapy held the leading position among Therapy Type segments in 2024, based on market size.
- Gene Therapy is projected to post the fastest growth rate, sustaining its position as the most attractive Therapy Type segment during the forecast horizon.
- In 2024, India accounted for 5.23% of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is expected to lead the global cell and gene therapy manufacturing qc market in terms of market size.
- Within Asia Pacific, China is projected to dominate the regional cell and gene therapy manufacturing qc market size by 2028.
- India is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 58503 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 116.84 Million |
| Market Size In 2028 | USD 305.8 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 27.3% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
India Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
India Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
India Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
